Killen Group’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$15.3M Buy
1,424,815
+276,467
+24% +$2.81M 1.77% 17
2015
Q4
$12.4M Buy
1,148,348
+14,549
+1% +$152K 1.28% 31
2015
Q3
$11M Sell
1,133,799
-198,015
-15% -$2.07M 1.03% 42
2015
Q2
$15M Buy
1,331,814
+700
+0.1% +$7.44K 1.14% 31
2015
Q1
$13.8M Buy
1,331,114
+131,536
+11% +$1.45M 0.99% 48
2014
Q4
$13.6M Buy
1,199,578
+1,300
+0.1% +$13.5K 0.89% 52
2014
Q3
$11.8M Buy
1,198,278
+388,198
+48% +$3.82M 0.66% 70
2014
Q2
$7.25M Buy
810,080
+500,744
+162% +$4.61M 0.38% 91
2014
Q1
$3.08M Buy
309,336
+6,922
+2% +$71K 0.17% 95
2013
Q4
$3.35M Buy
+302,414
New +$2.85M 0.19% 89

Other funds holding AORT

Killen Group's AORT Position: Q1 2016 in Review

Killen Group increased its Artivion (AORT) stake by 24% in Q1 2016, buying an estimated $2.81M and bringing the position to 1,424,815 shares worth $15.3M. The position accounts for 1.77% of the portfolio, ranked #17.

Killen Group first reported a position in AORT in Q4 2013 and has held it in 10 quarters since. 120 funds tracked by Wall St. Rank hold AORT as of Q1 2016.

  • Killen Group held 1,424,815 shares of Artivion worth $15.3M as of Q1 2016.
  • Killen Group bought 276,467 Artivion shares in Q1 2016, an estimated $2.81M.
  • Artivion made up 1.77% of Killen Group's portfolio in Q1 2016, its #17 holding.
  • Killen Group first reported a position in Artivion in Q4 2013 and has held it in 10 quarters since.
  • 120 funds tracked by Wall St. Rank held Artivion as of Q1 2016.

Based on Killen Group's 13F filing for Q1 2016, filed 27 Apr 2016.